The Checkup by Singlecare

OCTOBER 9, 2024

As a specialty medication , Humira requires specific handling, administration, and monitoring, so you have to get it from a specialty pharmacy or other designated location. Fortunately, the Food and Drug Administration (FDA) has approved several Humira biosimilars , including Amjevita, Cyltezo, Hadlima, and Yuflyma.

Insurance 52

Insurance Insurance Coverage Specialty Pharmacies Documentation 52

The Checkup by Singlecare

OCTOBER 9, 2024

Dupixent (dupilumab) is a brand-name monoclonal antibody drug that is approved by the Food and Drug Administration (FDA) to treat a variety of conditions. Sometimes, coverage isn’t as simple as showing your insurance card at the pharmacy. Most only issue coverage for treatments approved by the FDA. How much does Dupixent cost?

Insurance 52

Insurance Labelling Insurance Coverage Specialty Pharmacies 52

Drug Topics

JULY 7, 2025

The FDA has approved sebetralstat (Ekterly) for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients 12 years of age or older, according to a release from KalVista Pharmaceuticals. 1 The decision makes sebetralstat the first and only oral on demand treatment option for the condition. hours for placebo.

FDA 315

FDA Vaccines Specialty Pharmacies Compounding 315

Drug Topics

JULY 8, 2025

TCSs are the first-line anti-inflammatory treatment and their effectiveness and safety have been well documented.” The next step consists of treatment with topical anti-inflammatory therapies. Above all other medication classes and formulations, TCSs have been deemed as the most important pharmacotherapy in the treatment of AD.

Vaccines 466

Vaccines Specialty Pharmacies Compounding Communication 466

Pharmacy Times

JULY 2, 2025

On February 21, 2020, the FDA approved eptinezumab-jjmr (Vyepti; Lundbeck) as the first intravenous migraine preventative treatment for adults. They can collect documentation on prior preventive therapies, baseline MMDs, and follow-up outcomes to support prior authorization, including site-of-care arrangements. News release.

Compounding Pharmacies 130

Compounding Pharmacies FDA Immunization Specialty Pharmacies 130

Pharmacy Times

JULY 2, 2025

Unicycive plans to resolve FDA concerns by utilizing a second manufacturing vendor with a successful regulatory history to address manufacturing-related issues. The manufacturer reported that, as part of the NDA review, they have not highlighted any technical concerns related to the submitted documentation or testing of OLC.

FDA 73

FDA Compounding Pharmacies Vaccines Immunization 73

Pharmacy Times

JUNE 9, 2025

Pulmonary function tests and provider documentation were manually reviewed to confirm asthma diagnoses, while individuals with other pulmonary diseases were excluded. 1 The study also observed that 65% of patients had a documented visit with an asthma specialist during the follow-up period.

Compounding Pharmacies 73

Compounding Pharmacies Hospitals Immunization Chemotherapy 73

Pharmacy Times

JULY 9, 2025

2 Evidence Supporting Supplementation A randomized controlled trial involving high-dose vitamin D (300 IU/kg/day, up to 5000 IU/day) in children with ASD documented meaningful improvements in Childhood Autism Rating Scale (CARS) scores, repetitive behaviors, eye contact, and attention after 4 months, without toxicity.

Compounding Pharmacies 100

Compounding Pharmacies Immunization Specialty Pharmacies Compounding 100

Pharmacy Times

JULY 1, 2025

We all share the same electronic health record and document every patient interaction in the health record, and we have very easy access to reach out to the patient's provider to let them know of any questions or concerns that the patient has regarding their medication.

Specialty Pharmacies 65

Specialty Pharmacies Insurance Compounding Pharmacies Hospitals 65

Pharmacy Times

JUNE 17, 2025

If a discrepancy is found, the pharmacy nurses will hold the shipment, and a clinical intervention will be communicated to the provider. Results American Oncology Network (AON) Pharmacy collected data on waste and cost avoidance from February 2023 to September 2023. During this time frame, the pharmacy documented 152 interventions.

Mail-Order Pharmacies 73

Mail-Order Pharmacies Compounding Pharmacies Medical Records Dosage 73

Pharmacy Times

JUNE 23, 2025

We just must do a good job of documenting them and develop that clinical evidence base that supports it. Pharmacy Times: How do evolving guidelines influence the integration of CGMs into standard clinical practice for T2D? 100% of them said a GLP-1 would be more effective if you use the CGM with it, unanimous.

Insurance Coverage 65

Insurance Coverage Compounding Pharmacies Compounding Insurance 65

Pharmacy Times

JUNE 20, 2025

Other documented causes of secondary dysmenorrhea include fibroids, adenomyosis, infection, myomas, obstructive reproductive tract anomalies, and ovarian cysts About the Author Yvette C. Dysmenorrhea, also known as painful menstruation, is the most commonly reported menstrual symptom among females during the reproductive years.

Compounding Pharmacies 65

Compounding Pharmacies Hospitals Immunization Compounding 65

Pharmacy Times

JUNE 20, 2025

It’s also helpful to hear from managed care experts—understanding their concerns and what documentation is needed to ensure patients can get coverage for the latest treatments. I love that OPC is positioned so close to ASCO because pharmacists often can’t attend large meetings due to travel restrictions and limited funding.

Compounding Pharmacies 65

Compounding Pharmacies Immunization Mayo Clinic Hospitals 65

Pharmacy Times

JUNE 22, 2025

Pharmacy Times: What are the most significant benefits of CGM adoption for individuals with type 2 diabetes? Sayer: The most documented, most significant benefits If you take a look at the trials we've run, first of all, you always see an A1c reduction, because average glucose values go down and A1c follows.

Compounding Pharmacies 65

Compounding Pharmacies Hospitals Vaccines Immunization 65

The Checkup by Singlecare

OCTOBER 15, 2024

Before issuing coverage, the insurance provider typically wants to confirm that Remicade is medically necessary for you and that you’re using it to treat a condition the Food and Drug Administration (FDA) has approved it to treat.

Insurance Coverage 52

Insurance Coverage Insurance Specialty Pharmacies Customer Service 52

Drug Topics

JUNE 25, 2025

The properties of thimerosal were documented to contribute to the safe use of multidose vials and packaging of vaccines, such as seasonal and pandemic influenza vaccines. 2 Currently, there are 3 FDA-approved seasonal influenza vaccines that contain a concentration of mercury, as evident from January 15, 2025, on the CDC website.

Vaccines 387

Vaccines Immunization Independent Pharmacies Compounding 387

Pharmaceutical Commerce

JUNE 18, 2025

Stakeholders are aware that this federal law—enforced by the FDA and originally enacted in 2013 as a way to help bolster security and traceability of products passing through the pharma supply chain—has seen its share of delays and exemptions over the years. Next on the docket are wholesale distributors, who have until Aug.

Specialty Pharmacies 52

Specialty Pharmacies Documentation FDA 52